patent

  • US Supreme Court clears way for generic patent challenges

    After the ruling, generic manufacturers will now be able to challenge the content of patent descriptions and, if successful, ultimately force approval of the ANDA. Writing for the Court in a unanimous decision, Justice Elena Kagan chastised the FDA for using ambiguous or opaque guidelines and forms that lend to the confusion surrounding patent decisions.

    patent | 18 May 2012

  • Drug Process Licensing Associates publishes third process patent

    Patent filed for Sitagliptin used to lower blood sugar levels in patients with type 2 diabetes.

    patent | 20 September 2011

  • CEL-SCI receives key Chinese patent for its investigational cancer therapy Multikine

    CEL-SCI Corporation announced that the Chinese patent office has issued a key patent covering CEL-SCI’s investigational cancer drug, Multikine (Leukocyte Interleukin, Injection). The patent, Chinese patent number ZL200480025403.6, is titled, “A M…

    patent | 18 August 2011

  • Biomoda granted patent in Japan

    Cancer diagnostics company Biomoda Inc received notification that the Japan Patent Office has granted the company’s patent application. This relates to a method of using its proprietary porphyrin-based compound that binds to cancer cells and causes…

    patent | 07 July 2011

  • Pharmigene secures patents to warfarin dosage predictor

    Pharmigene announced it has been granted patents in Europe, Japan, New Zealand, Mexico, Singapore, and Taiwan. The patents are related to methods used to predict dosage of the widely-prescribed anti-coagulant drug warfarin based on genetic variations…

    patent | 03 June 2011

  • Pro-Pharmaceuticals expands patent coverage to Japan

    Pro-Pharmaceuticals Inc announced that the Japan Patent Office has accepted a new patent, No. 2002-574987, “Co-administration of a Polysaccharide with a Chemotherapy for the Treatment of Cancer”. The patent protects, among other things, methods f…

    patent | 26 April 2011

  • EU grants patent to TauRx

    TauRx Pharmaceuticals has been granted a European patent for its lead compound LMTX, a next generation treatment for Alzheimer’s and other neurodegenerative diseases associated with Tau protein mis-folding. TauRx has also received a US notific…

    patent | 24 February 2011

  • MabCure files provisional patent for ovarian cancer antibodies

    MabCure announces it has filed a provisional patent application for its ovarian cancer diagnostic antibodies with the US Patent and Trademark Office. The filing was based on positive results of a recent study that showed MabCure’s tumor-specific m…

    patent | 24 August 2010

  • Patent analysis software advances freedom-to-operate

    Genedata , announces the release of PatentExplorer, an interdisciplinary software tool for assessing the patent situation of novel biomolecules and targets. Part of the Genedata Phylosopher biological data management system, PatentExplorer integ…

    patent | 06 August 2010

  • Sloning Strengthens Intellectual Property with US Patent

    Sloning, leading supplier of synthetic biology tools was awarded US Patent No, 7,695,906. The former’s enabling platform technology – Slonomics, allows researchers to increase the success rate of their screening for new and optimized therapeutic …

    patent | 06 May 2010

Page 1 Next > Last >>